Home/Filings/4/0001213900-24-047096
4//SEC Filing

WOUDENBERG MICHAEL 4

Accession 0001213900-24-047096

CIK 0001728328other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 4:27 PM ET

Size

5.5 KB

Accession

0001213900-24-047096

Insider Transaction Report

Form 4
Period: 2024-05-27
WOUDENBERG MICHAEL
VP, Chem/Manufacturing/Control
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2024-05-2739475,100 total
    Exercise: $263.18From: 2019-05-27Exp: 2024-05-27Common shares (394 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817884

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:27 PM ET
Size
5.5 KB